Reference health
FDA-approved 5-HT1F receptor agonist lasmiditan induces mitochondrial biogenesis and enhances locomotor and blood-spinal cord barrier recovery after spinal cord injury
50/50 checkable references clean · checked 2026-07-23
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
4 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 50 checked references that resolve
resolves10.1038/nature06613
HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1α
resolves10.1089/neu.2006.23.635
Basso Mouse Scale for Locomotion Detects Differences in Recovery after Spinal Cord Injury in Five Common Mouse Strains
resolves10.1016/j.ab.2010.04.040
A high-throughput respirometric assay for mitochondrial biogenesis and toxicity
resolves10.1523/JNEUROSCI.1067-07.2007
Long-Term Consequences of Methamphetamine Exposure in Young Adults Are Exacerbated in Glial Cell Line-Derived Neurotrophic Factor Heterozygous Mice
resolves10.1177/0333102419864132
Interim results of a prospective, randomized, open-label, Phase 3 study of the long-term safety and efficacy of lasmiditan for acute treatment of migraine (the GLADIATOR study)
resolves10.1016/S0028-3908(97)00061-0
Differential Distribution of [ 3 H]Sumatriptan Binding Sites (5-HT 1B , 5-HT 1D and 5-HT 1F Receptors) in Human Brain: Focus on Brainstem and Spinal Cord
resolves10.1002/nbm.1343
Blood–spinal cord barrier permeability in experimental spinal cord injury: dynamic contrast‐enhanced MRI
resolves10.1016/j.bcp.2019.113644
The 5-hydroxytryptamine receptor 1F stimulates mitochondrial biogenesis and angiogenesis in endothelial cells
resolves10.1159/000430107
Dexmedetomidine Attenuates Blood-Spinal Cord Barrier Disruption Induced by Spinal Cord Ischemia Reperfusion Injury in Rats
resolves10.1089/neu.2013.3034
Characterization of Vascular Disruption and Blood–Spinal Cord Barrier Permeability following Traumatic Spinal Cord Injury
resolves10.1124/jpet.114.214700
Agonism of the 5-Hydroxytryptamine 1F Receptor Promotes Mitochondrial Biogenesis and Recovery from Acute Kidney Injury
resolves10.1152/ajprenal.00077.2018
5-HT<sub>1F</sub> receptor regulates mitochondrial homeostasis and its loss potentiates acute kidney injury and impairs renal recovery
resolves10.1152/ajprenal.00324.2017
Identification of dual mechanisms mediating 5-hydroxytryptamine receptor 1F-induced mitochondrial biogenesis
resolves10.1007/s11064-015-1606-1
The Neuroprotective Effect of Tetramethylpyrazine Against Contusive Spinal Cord Injury by Activating PGC-1α in Rats
resolves10.1007/s12035-016-9910-6
Propitious Therapeutic Modulators to Prevent Blood-Spinal Cord Barrier Disruption in Spinal Cord Injury
resolves10.1007/s12035-017-0509-3
Matrix Metalloproteinase-8 Inhibition Prevents Disruption of Blood–Spinal Cord Barrier and Attenuates Inflammation in Rat Model of Spinal Cord Injury
resolves10.1152/jn.01011.2010
Polysynaptic excitatory postsynaptic potentials that trigger spasms after spinal cord injury in rats are inhibited by 5-HT<sub>1B</sub>and 5-HT<sub>1F</sub>receptors
resolves10.1097/BRS.0000000000002629
Synchrotron Radiation Imaging Reveals the Role of Estrogen in Promoting Angiogenesis After Acute Spinal Cord Injury in Rats
resolves10.1016/S0014-2999(99)00114-4
Characterisation of 5-HT receptors in human coronary arteries by molecular and pharmacological techniques
resolves10.2147/JPR.S152216
Lasmiditan for the treatment of acute migraine: a review and potential role in clinical practice
resolves10.55782/ane-2011-1848
Secondary injury mechanisms in traumatic spinal cord injury: a nugget of this multiply cascade
resolves10.1089/neu.2008.0860
Effect of VEGF Treatment on the Blood-Spinal Cord Barrier Permeability in Experimental Spinal Cord Injury: Dynamic Contrast-Enhanced Magnetic Resonance Imaging
resolves10.1016/j.expneurol.2017.03.021
Pioglitazone treatment following spinal cord injury maintains acute mitochondrial integrity and increases chronic tissue sparing and functional recovery
resolves10.1016/j.pharmthera.2011.05.001
Pharmacological interventions for spinal cord injury: Where do we stand? How might we step forward?
resolves10.1016/j.ajpath.2012.09.003
PGC-1α Regulates Normal and Pathological Angiogenesis in the Retina
resolves10.1111/nyas.13436
Blood–spinal cord barrier breakdown and pericyte deficiency in peripheral neuropathy
resolves10.1124/jpet.117.244806
Mitochondrial-Based Therapeutics for the Treatment of Spinal Cord Injury: Mitochondrial Biogenesis as a Potential Pharmacological Target
resolves10.1111/bph.14076
5‐HT<sub>1F</sub> receptor‐mediated mitochondrial biogenesis for the treatment of Parkinson's disease
resolves10.1089/neu.2018.5669
Pharmacological Stimulation of Mitochondrial Biogenesis Using the Food and Drug Administration-Approved β
<sub>2</sub>
-Adrenoreceptor Agonist Formoterol for the Treatment of Spinal Cord Injury
resolves10.1016/j.expneurol.2019.113064
β2-adrenergic receptor-mediated mitochondrial biogenesis improves skeletal muscle recovery following spinal cord injury
resolves10.1186/s10194-019-1044-6
Lasmiditan for acute treatment of migraine in patients with cardiovascular risk factors: post-hoc analysis of pooled results from 2 randomized, double-blind, placebo-controlled, phase 3 trials
resolves10.1016/j.expneurol.2020.113309
Mitochondrial biogenesis as a therapeutic target for traumatic and neurodegenerative CNS diseases
resolves10.55782/ane-2014-1983
The role of serotonin in the control of locomotor movements and strategies for restoring locomotion after spinal cord injury
resolves10.1002/jnr.20292
Mitochondrial permeability transition in CNS trauma: Cause or effect of neuronal cell death?
resolves10.1089/neu.2006.0242
Temporal Characterization of Mitochondrial Bioenergetics after Spinal Cord Injury
resolves10.4238/2015.April.17.4
Neuroprotective effect of ketamine on acute spinal cord injury in rats
resolves10.1074/jbc.M114.554394
Hypoxic Induction of Vascular Endothelial Growth Factor (VEGF) and Angiogenesis in Muscle by Truncated Peroxisome Proliferator-activated Receptor γ Coactivator (PGC)-1α
resolves10.1038/srep36286
Peripheral and spinal 5-HT receptors participate in cholestatic itch and antinociception induced by bile duct ligation in rats
resolves10.4103/1673-5374.232484
Endothelial progenitor cell-conditioned medium promotes angiogenesis and is neuroprotective after spinal cord injury
resolves10.3389/fphar.2018.00858
Hydrogen Sulfide Ameliorates Blood-Spinal Cord Barrier Disruption and Improves Functional Recovery by Inhibiting Endoplasmic Reticulum Stress-Dependent Autophagy
resolves10.1146/annurev-pharmtox-010715-103155
Mitochondrial Biogenesis as a Pharmacological Target: A New Approach to Acute and Chronic Diseases
resolves10.1124/jpet.112.191528
The β2-Adrenoceptor Agonist Formoterol Stimulates Mitochondrial Biogenesis
resolves10.5582/bst.2016.01062
Effect of lycopene on the blood-spinal cord barrier after spinal cord injury in mice
resolves10.18632/oncotarget.13777
The cross-talk between autophagy and endoplasmic reticulum stress in blood-spinal cord barrier disruption after spinal cord injury
The 4 references without a DOI — listed, not checked
no DOI — not checkedThe role of the serotonergic system in locomotor recovery after spinal cord injury
no DOI — not checked5-HT1F receptor-mediated mitochondrial biogenesis for the treatment of Parkinson’s disease
no DOI — not checkedPharmacological stimulation of mitochondrial biogenesis using the FDA-approved beta<sub>2</sub>−adrenoreceptor agonist formoterol for the treatment of spinal cord injury
no DOI — not checked5-HT1F receptor agonist induces mitochondrial biogenesis and promotes recovery from spinal cord injury
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1016/j.expneurol.2021.113720"><img src="https://citestamp.com/citestamped/10.1016/j.expneurol.2021.113720/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1016/j.expneurol.2021.113720)